Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Revenue (2020 - 2025)

Journey Medical's Revenue history spans 6 years, with the latest figure at $15.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 22.5% year-over-year to $15.5 million, compared with a TTM value of $60.6 million through Dec 2025, up 9.97%, and an annual FY2025 reading of $61.2 million, up 11.07% over the prior year.
  • Revenue for Q4 2025 was $15.5 million at Journey Medical, down from $17.0 million in the prior quarter.
  • The five-year high for Revenue was $23.3 million in Q1 2022, with the low at $10.7 million in Q1 2021.
  • Average Revenue over 5 years is $15.5 million, with a median of $15.3 million recorded in 2023.
  • Year-over-year, Revenue soared 117.33% in 2022 and then tumbled 47.78% in 2023.
  • Tracing DERM's Revenue over 5 years: stood at $17.5 million in 2021, then fell by 24.12% to $13.3 million in 2022, then grew by 14.78% to $15.3 million in 2023, then fell by 17.28% to $12.6 million in 2024, then grew by 22.5% to $15.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Revenue are $15.5 million (Q4 2025), $17.0 million (Q3 2025), and $15.0 million (Q2 2025).